Willdan raised its full-year 2025 targets, now expecting net revenue between $360 million and $365 million, adjusted EBITDA in the range of $77 million to $78 million, and adjusted diluted EPS ...
Hosted on MSN
Heron Therapeutics outlines $153M–$163M net revenue target as acute care momentum accelerates
CEO Craig Collard opened with the announcement of successful completion of financing, stating: "This has been an overhang on the company since I joined, and we're glad to have it behind us. With this ...
Hosted on MSN
Bowman signals $465M–$480M net revenue target for 2026 while expanding power and transportation segments
Earnings Call Insights: Bowman Consulting Group Ltd. (BWMN) Q3 2025 Gary Bowman, Founder, CEO & Director, emphasized that "for the first time, we surpassed a $500 million annualized gross revenue pace ...
Management maintained its guidance for the EXXUA launch, with Disbrow stating, "the EXXUA launch remains on track to occur by the end of calendar '25." Selhorn outlined expectations, "We plan to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback